Seabridge Gold Inc. (SEA)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 34.16 |
|---|---|
| 52-week range | 30.25 – 54.29 |
| Return, 1 month / 3 months | −22.4% / −6.8% |
| Return, 1 year / 3 years | +11.1% / +162.1% |
| Trend | Below its 200-day average |
| RSI (14) | 32 |
| Volatility (1 year) | 66.5% |
| Worst drawdown (1 year) | -37.4% |
| Average daily value traded | 3.70M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Seabridge Gold is a Canadian resource company based in Toronto that acquires and explores gold properties. Its main asset is the KSM project in northwestern British Columbia, a large gold and copper deposit, and it also holds other exploration properties in Canada, including Courageous Lake in the Northwest Territories. The company works on advancing these deposits through drilling, engineering studies and permitting, and its activities are aimed at resource development rather than producing metal from operating mines.
On this site Seabridge Gold Inc. appears as a stock on the Toronto Exchange (Canada), code SEA, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Seabridge Gold Inc. (SEA) trades on the Toronto Exchange in Canada. It last closed at CAD 34.16 on 23 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 568 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 11.1% and over the last three months it fell 6.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 37 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -15.4% | ||
| From 52-week high | -36.4% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -6.8% | ||
| 6-month return | -11.8% | ||
| 12-month return, skipping the last month | 43.2% | ||
| Stability (higher is calmer) | 31 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 66.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.4% | ||
| Liquidity | 67 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.70M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −7.2% |
|---|---|
| 1 month | −22.4% |
| 3 months | −6.8% |
| 6 months | −11.8% |
| 1 year | +11.1% |
| 3 years | +162.1% |
| 5 years | +117.5% |
Signals
| 50-day / 200-day average | 41.75 / 40.36 |
|---|---|
| Golden / death cross (60 days) | Golden, 45 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.73 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Dec 2023 | CAD 1.5865 |
| 23 Dec 2022 | CAD 2.7732 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.